Thromboprophylaxis decreases the risk of pulmonary embolism in COVID-19

Aim: Pulmonary embolism caused by micromboli and microthrombuses might be associated with increased mortality morbidity in Covid-19. Routine thromboprophylaxis application contribute to clinical recovery reducing the risk of pulmonary embolism. In this study, effects on outcomes were investigated examining rates computed tomographic angiography requests for differential diagnosis patients Materials Methods: Patients who underwent tomography (CT) between 10 March 25 May 2020 our hospital retrospectively analysed. received simultaneous PCR tests during CT examination included study. follow-up these patients, request suspicion it’s investigated. Results: During study period, thorax was performed 11142 161 (1.4%) them. Ninety-nine test hospitalization period positive 22% (n = 21) (22%) detected 6 them (6.3%). negative 74 (78%) 17 (17.9%) had Conclusion: contributes treatment Covid-19 preventing development microthrombosis thrombotic complications respiratory system.